DIFFERENTIAL EFFECTS ON ACTION POTENTIAL DURATION OF CLASS IA, B AND C ANTIARRHYTHMIC DRUGS: MODULATION BY STIMULATION RATE AND EXTRACELLULAR K+ CONCENTRATION
- 1 August 1991
- journal article
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 18 (8) , 533-541
- https://doi.org/10.1111/j.1440-1681.1991.tb01488.x
Abstract
1. Standard microelectrode techniques were used to study the effects on the action potential duration (APD) of canine Purkinje fibres of a therapeutic concentration of nine Class I antiarrhythmic drugs. At an extracellular K+ concentration of 5.6 mmol/L all nine agents reduced APD at all drive rates studied (range of interstimulus intervals = 200-1000 ms). At lower levels of K+, quinidine (5 mumol/L) and disopyramide (10 mumol/L) (Class Ia agents) revealed dual effects on APD. At the lowest levels of K+ (2 mmol/L) and the longest interstimulus interval used (2000 ms), both agents significantly prolonged APD. Under all other conditions, APD was either unchanged or reduced. Lignocaine, 15 mumol/L (Class Ib agent) reduced APD at all rates and all K+ concentrations and this effect was greatest at the slowest rates. 2. Flecainide (1 mumol/L) (Class Ic) shortened APD at K+ = 5.6 and 4 mmol/L but had no effect at K+ = 2 mmol/L. 3. We conclude that these data result from opposing drug actions on inward sodium and outward potassium currents flowing during the plateau of the action potential. 4. Class Ia drugs exhibit significant depression of both currents, with the resultant effect on APD being modulated by external K+ concentration and drive rate. 5. Class Ib agents predominantly depress the sodium current and hence shorten APD, and Ic compounds have intermediate actions. 6. These differential effects on APD must be considered when planning antiarrhythmic therapy, and are directly relevant to the proarrhythmic propensities of these agents.Keywords
This publication has 28 references indexed in Scilit:
- Proarrhythmic actions of antiarrhythmic drugs: a reviewAustralian and New Zealand Journal of Medicine, 1990
- Effects of lidocaine and quinidine on post-repolarization refractoriness after the basic and premature action potentials: Consideration of aim of antiarrhythmic drug therapyAmerican Heart Journal, 1989
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionNew England Journal of Medicine, 1989
- Pharmacological response of quinidine induced early afterdepolarisations in canine cardiac Purkinje fibres: insights into underlying ionic mechanismsCardiovascular Research, 1988
- Antiarrhythmic Agents: The Modulated Receptor Mechanism of Action of Sodium and Calcium Channel-Blocking DrugsAnnual Review of Pharmacology and Toxicology, 1984
- A Classification of Antiarrhythmic Actions Reassessed After a Decade of New DrugsThe Journal of Clinical Pharmacology, 1984
- Antiarrhythmic Agents: The Modulated Receptor Mechanism of Action of Sodium and Calcium Channel-Blocking DrugsAnnual Review of Pharmacology and Toxicology, 1984
- Flecainide-induced QT prolongation and ventricular tachycardiaAmerican Heart Journal, 1982
- Electrophysiologic effects of disopyramide phosphate on the spontaneous action potential and membrane current systems of the rabbit atrioventricular nodeThe American Journal of Cardiology, 1982
- Effect of lidocaine hydrochloride on membrane conductance in mammalian cardiac purkinje fibersJournal of Clinical Investigation, 1972